Skip to main content

Omega Therapeutics, Inc. (OMGA)

NASDAQ: OMGA · IEX Real-Time Price · USD
20.34 0.69 (3.51%)
Oct 15, 2021 4:00 PM EDT - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Year20202019
Selling, General & Admin
6.244.23
Research & Development
21.0611.93
Other Operating Expenses
1.321.17
Operating Expenses
28.6217.33
Operating Income
-28.62-17.33
Interest Expense / Income
0.780.6
Other Expense / Income
0.050.02
Pretax Income
-29.45-17.95
Net Income
-29.45-17.95
Net Income Common
-29.45-17.95
Shares Outstanding (Basic)
1513
Shares Outstanding (Diluted)
1513
Shares Change
17.69%-
EPS (Basic)
-2.00-1.43
EPS (Diluted)
-2.00-1.43
Free Cash Flow Per Share
-1.89-1.32
EBITDA
-27.52-16.56
EBIT
-28.67-17.35